Literature DB >> 8843370

In vivo MR imaging and spectroscopy using hyperpolarized 129Xe.

M E Wagshul1, T M Button, H F Li, Z Liang, C S Springer, K Zhong, A Wishnia.   

Abstract

Hyperpolarized 129Xe has been used to obtain gas phase images of mouse lung in vivo, showing distinct ventilation variation as a function of the breathing cycle. Spectra of 129Xe in the thorax show complex structure in both the gas phase (-4 to 3 ppm) and tissue-dissolved (190-205 ppm) regions. The alveolar gas peak shows correlated intensity and frequency oscillations, both attributable to changes in lung volume during breathing. The two major dissolved peaks near 195-200 ppm are attributed to lung parenchyma and to blood; they reach maximum intensity in 5-10 s and decay with an apparent T1 of 30 s. Another peak at 190 ppm takes 20-30 s to reach maximum; this must represent other well-vascularized tissue (e.g., heart and other muscles) in the thorax. The maximum integrated area of the tissue components reaches 30-80% of the maximum alveolar gas area, indicating that imaging at tissue frequencies can be achieved.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8843370     DOI: 10.1002/mrm.1910360203

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  25 in total

1.  Vascular and perfusion imaging using encapsulated laser-polarized helium.

Authors:  V Callot; E Canet; J Brochot; Y Berthezène; M Viallon; H Humblot; A Briguet; H Tournier; Y Crémillieux
Journal:  MAGMA       Date:  2001-03       Impact factor: 2.310

2.  Visualization of gas flow and diffusion in porous media.

Authors:  L G Kaiser; T Meersmann; J W Logan; A Pines
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

3.  Simultaneous magnetic resonance imaging of ventilation distribution and gas uptake in the human lung using hyperpolarized xenon-129.

Authors:  John P Mugler; Talissa A Altes; Iulian C Ruset; Isabel M Dregely; Jaime F Mata; G Wilson Miller; Stephen Ketel; Jeffrey Ketel; F William Hersman; Kai Ruppert
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-22       Impact factor: 11.205

4.  Transverse relaxation rates of pulmonary dissolved-phase Hyperpolarized 129 Xe as a biomarker of lung injury in idiopathic pulmonary fibrosis.

Authors:  Jeff Kammerman; Andrew D Hahn; Robert V Cadman; Annelise Malkus; David Mummy; Sean B Fain
Journal:  Magn Reson Med       Date:  2020-03-11       Impact factor: 4.668

5.  Establishing an accurate gas phase reference frequency to quantify 129 Xe chemical shifts in vivo.

Authors:  Rohan S Virgincar; Scott H Robertson; John Nouls; Simone Degan; Geoffry M Schrank; Mu He; Bastiaan Driehuys
Journal:  Magn Reson Med       Date:  2016-04-05       Impact factor: 4.668

6.  In vivo magnetic resonance vascular imaging using laser-polarized 3He microbubbles.

Authors:  M S Chawla; X J Chen; H E Möller; G P Cofer; C T Wheeler; L W Hedlund; G A Johnson
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

7.  In vivo NMR and MRI using injection delivery of laser-polarized xenon.

Authors:  B M Goodson; Y Song; R E Taylor; V D Schepkin; K M Brennan; G C Chingas; T F Budinger; G Navon; A Pines
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

8.  NMR of laser-polarized xenon in human blood.

Authors:  A Bifone; Y Q Song; R Seydoux; R E Taylor; B M Goodson; T Pietrass; T F Budinger; G Navon; A Pines
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

9.  Assessment of lung function in asthma and COPD using hyperpolarized 129Xe chemical shift saturation recovery spectroscopy and dissolved-phase MRI.

Authors:  Kun Qing; John P Mugler; Talissa A Altes; Yun Jiang; Jaime F Mata; G Wilson Miller; Iulian C Ruset; F William Hersman; Kai Ruppert
Journal:  NMR Biomed       Date:  2014-08-22       Impact factor: 4.044

Review 10.  Hyperpolarized 129Xe MRI of the human lung.

Authors:  John P Mugler; Talissa A Altes
Journal:  J Magn Reson Imaging       Date:  2013-02       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.